Geron updates risk factors and corporate presentation; no material new event

GERON CORP

Updated risk factor disclosure emphasizes sole reliance on imetelstat and risks of clinical trial failures.
Corporate presentation dated March 2024 made available on company website.
No specific new clinical, financial, or regulatory event; risks remain consistent with prior filings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.